SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is experiencing high volatility as traders react to conflicting reports regarding the status of the Strait of Hormuz and ongoing U.S.-Iran negotiations. The community is deeply divided between those betting on a rapid supply-driven price crash following potential de-escalation and those anticipating further spikes due to persistent geopolitical instability and tight energy inventories.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and significant selling pressure, with community sentiment deeply polarized between investors viewing the recent decline as a forced liquidation event and those identifying a generational buying opportunity. The ongoing debate centers on the sustainability of Saylor's BTC-accumulation strategy, the burden of rising dividend obligations from preferred securities, and the stock's weakening correlation with Bitcoin price action.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is experiencing significant volatility driven by index reconstitution selling and a specific pause in a Wyoming data center project, causing investors to weigh these temporary headwinds against the company's long-term role in AI power infrastructure. The community remains largely polarized, with many using the sharp price pullback as a high-conviction buying opportunity while others express caution regarding valuation sustainability and recent technical breakdowns.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on potential inclusion in the Russell 1000 index, driving significant options activity and ongoing conflict between bullish sentiment and short sellers.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing heightened activity and investor interest driven by persistent buyout rumors and significant trading volume, as the community debates whether the stock is undervalued given its product portfolio and cash position. Shareholders remain deeply divided, with some betting on a potential hostile takeover or acquisition while others express frustration over leadership and the stock's failure to maintain momentum.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor reports of a potential Japanese delegation visiting Greenland to evaluate rare earth opportunities, fueling hopes for strategic partnerships that could bypass Chinese supply chains. While the community remains divided on the pace of project development and communication, many shareholders are highlighting the stock's long-term potential as a critical component of Western defense and industrial supply independence.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors digest the announcement of a late July FDA Advisory Committee meeting for Deramiocel, alongside new five-year data highlighting the therapy's durability. While some community members express concern over the potential for added volatility or delays, the majority of the discussion remains bullish, focusing on the FDA's shift toward increased transparency and the company's strong clinical evidence as catalysts for an imminent approval.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as retail investors weigh the recent loss of a key Medicare reimbursement court case against the company's strong revenue growth and upcoming clinical milestones. The community is actively debating whether the stock is undervalued or if potential institutional sell-offs and the impact of competing therapies will continue to weigh on the share price in the near term.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending as the community reacts to a new distribution deal with NBCUniversal that restores key sports and entertainment channels ahead of the FIFA World Cup. While bulls view the partnership and market scale as a turnaround catalyst, skeptics remain focused on long-term stock performance and persistent volatility.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is experiencing significant volatility and volume as it navigates FTSE Russell index rebalancing pressures and investor debates regarding the efficiency of its massive AI and cloud capital expenditures. The stock is currently being closely monitored for a potential rebound as institutional interest builds around its role as a key hyperscaler and long-term infrastructure compounder.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

3 Reasons Growth Investors Will Love Argan (AGX)

Argan (AGX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Argan (AGX) is a Great Momentum Stock: Should You Buy?

Does Argan (AGX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Industry Outlook United Rentals, Simpson, Everus and Construction Partners

United Rentals, Simpson, Everus and Construction Partners have been highlighted in this Industry Outlook article.

5 Building Product Stocks to Buy Despite Industry Headwinds

Tariffs, inflation and housing headwinds weigh on the industry. Yet, URI, AGX, SSD, ECG and ROAD stocks look primed to benefit from infrastructure and innovation tailwinds.

Is CRH's $8.5 Billion Arcosa Acquisition a Game Changer?

CRH's $8.5B Arcosa deal is likely to expand its aggregates footprint, boost infrastructure exposure and deliver synergies despite integration risks.

Taiwan Semiconductor, Primoris Services, Micron And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures lower, Nasdaq 100 down 2%. Taiwan Semi (NYSE: TSM) fell 4.3%, Argan (NYSE: AGX) down 12.7%. Other stocks also decline in pre-market.read more...

3 Best Low-Beta Stocks to Buy Right Away: LQDA, FLXS & AGX

LQDA, FLXS and AGX screen as low-beta stocks with positive price moves, solid trading volume and company-specific growth drivers amid market fears.

Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns

ALHC, AGX, AGYS and CIEN make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.

Argan Stock Soars 53% in Past 3 Months: Is It the Right Time to Buy?

Has AGX stock's 53% surge been backed by fundamentals, or is its premium valuation raising the bar?

Argan's Backlog Is 79% Gas-Focused: Can Power Demand Fuel Upside?

AGX's gas-heavy backlog and rising power demand are boosting visibility as major U.S. projects position it for infrastructure growth.

Argan, Inc. is a construction company, which engages in the operations of its wholly owned subsidiaries. The firm operates through the following business segments: Power, Industrial, and Teledata. The Power segment includes engineering, procurement, construction, commissioning, maintenance, project development, and technical consulting services to the power generation market. The Industrial segment offers primarily on-site services that support new plant construction and additions, maintenance turnarounds, shutdowns, and emergency mobilizations for industrial plants. The Teledata segment provides project management, construction, installation, maintenance, repair, and emergency response services. It also operates through the following geographical segments: United States, Republic of Ireland, and United Kingdom. The company was founded by Rainer H. Bosselmann in May 1961 and is headquartered in Arlington, VA.

Argan, Inc.

Argan Stock Hit 52-Week High Today – Know What Wall Street Is Saying

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$765.46
Prev Close	$753.07
Open	$736.57
Dividend Yield	0.50%
50-Day Moving Average	$671.87
Beta	1.31
Avg. Volume	286,644.11
PE Ratio	66.16

52-Week High	$791.38
52-Week Low	$196.90
Market Capitalization	$10.56B
EPS (Annual)	$9.74
Price to Book	22.30
Revenue Per Employee	$670,408.80

Feed

News

Sentiment

Earnings

Fundamentals

Info

AGXArgan, Inc.

Latest AGX News